VF
INSY

Virtu Financial’s Insys Therapeutics, Inc. INSY Stock Holding History

Virtu Financial’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-34,988
Closed -$253K – 2512
2018
Q2 		$253K Sell
34,988
-1,536
-4% -$10.7K 0.02% 1302
2018
Q1 		$221K Buy
36,524
+16,463
+82% +$136K 0.01% 1283
2017
Q4 		$193K Buy
20,061
+9,866
+97% +$64.6K 0.01% 1704
2017
Q3 		$91K Buy
+10,195
New +$105K ﹤0.01% 2105

Other funds holding INSY

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Virtu Financial's INSY Position: Q3 2018 in Review

Virtu Financial sold out of Insys Therapeutics, Inc. (INSY) in Q3 2018, closing a stake of 34,988 shares — an estimated $253K sold.

Virtu Financial first reported a position in INSY in Q3 2017 and held it in 4 quarters. The position peaked at $253K in Q2 2018. 110 funds tracked by Wall St. Rank hold INSY as of Q3 2018.

  • Virtu Financial reported no remaining Insys Therapeutics, Inc. position as of Q3 2018 after selling out during the quarter.
  • Virtu Financial sold 34,988 Insys Therapeutics, Inc. shares in Q3 2018, an estimated $253K.
  • Virtu Financial first reported a position in Insys Therapeutics, Inc. in Q3 2017 and held it in 4 quarters.
  • Virtu Financial's Insys Therapeutics, Inc. position peaked at $253K in Q2 2018.
  • 110 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q3 2018.

Based on Virtu Financial's 13F filing for Q3 2018, filed 13 Nov 2018.